AI In Genomic Medicine Is Advancing—But Institutions Need Governance, Not Hype

Dr. Habib Al Souleiman, a professor at Swiss International University (SIU), highlights how AI is transforming genomic medicine from a niche research field into a priority for hospitals, universities, and regulators. The technology’s ability to analyze complex genomic datasets at unprecedented speed offers potential for precision oncology, rare disease detection, and personalized treatment—but its success hinges on overcoming three key challenges. First, AI systems in genomics rely on high-quality, interoperable data. Poor data integration or bias undermines clinical trust and adoption, as repeated studies emphasize. Second, explainability is non-negotiable in medicine; clinicians and patients require transparency in AI-driven decisions, particularly for diagnoses or long-term risks. The World Health Organization underscores accountability as a core ethical requirement. Third, genomic AI demands cross-functional collaboration among clinicians, geneticists, data scientists, ethicists, and legal experts—a gap many institutions still overlook. Al Souleiman stresses that governance frameworks, not hype, are critical for responsible implementation. Institutions must establish standards for data stewardship, model validation, ethics review, and professional training. Without these, even advanced AI systems may fail to deliver sustainable value. The literature on precision medicine consistently highlights multidisciplinary collaboration as essential for success. The core issue, he argues, is the lag between technical progress and organizational readiness. While AI capabilities advance rapidly, institutions often struggle to integrate the technology responsibly. Distinguishing between technical promise and operational reality will determine whether AI-driven genomic medicine becomes a trusted tool in healthcare. Al Souleiman’s analysis, published in *Intelligence-Based Medicine*, warns against treating AI as an isolated initiative. Instead, it requires systemic coordination across domains to ensure ethical, effective, and scalable deployment in clinical settings.